Serina Therapeutics, Inc.: 10-Q filed 2026-08-13
What Serina Therapeutics, Inc. reported in its quarterly report filed 2026-08-13 (fiscal Q2 2026): 36 published measures, 110 facts as tagged in accession 0001708599-26-000047.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2026-08-13
- Fiscal period
- fiscal Q2 2026
- Accession
- 0001708599-26-000047 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Serina Therapeutics, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 25,814,000 | USD | |
| At 2025-12-31 | 6,951,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 7,084,000 | USD | |
| At 2025-12-31 | 6,988,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 23,024,000 | USD | |
| At 2025-12-31 | 3,056,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -6,356,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -13,254,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | -6,448,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -11,261,000 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | -11,252,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | -8,072,000 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 53,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 46,000 | USD | 181 |
Contract revenue excluding tax
Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 0 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 0 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 130,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 130,000 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | 31,259,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 10,487,000 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | -53,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | -46,000 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | -76,754,000 | USD | |
| At 2025-12-31 | -63,500,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 16,385,000 | shares | 91 |
| 2026-01-01 to 2026-06-30 | 14,232,000 | shares | 181 |
| 2025-04-01 to 2025-06-30 | 10,004,000 | shares | 91 |
| 2025-01-01 to 2025-06-30 | 9,883,000 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 16,385,000 | shares | 91 |
| 2026-01-01 to 2026-06-30 | 14,232,000 | shares | 181 |
| 2025-04-01 to 2025-06-30 | 10,004,000 | shares | 91 |
| 2025-01-01 to 2025-06-30 | 9,883,000 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -0.55 | USD/shares | 91 |
| 2026-01-01 to 2026-06-30 | -1.11 | USD/shares | 181 |
| 2025-04-01 to 2025-06-30 | -0.66 | USD/shares | 91 |
| 2025-01-01 to 2025-06-30 | -1.15 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -0.55 | USD/shares | 91 |
| 2026-01-01 to 2026-06-30 | -1.11 | USD/shares | 181 |
| 2025-04-01 to 2025-06-30 | -0.66 | USD/shares | 91 |
| 2025-01-01 to 2025-06-30 | -1.15 | USD/shares | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 482,000 | USD | |
| At 2025-12-31 | 465,000 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -6,784,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -13,064,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | -5,565,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -11,423,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 25,030,000 | USD | |
| At 2025-12-31 | 6,080,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 3,762,000 | USD | |
| At 2025-12-31 | 3,563,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 1,858,000 | USD | |
| At 2025-12-31 | 1,931,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 6,784,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 13,064,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 5,695,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 11,553,000 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 3,816,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 7,015,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 3,152,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 6,103,000 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 25,400,000 | shares | |
| At 2025-12-31 | 10,767,000 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 95,481,000 | USD | |
| At 2025-12-31 | 58,536,000 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 0 | USD | |
| At 2025-12-31 | -14,000 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 18,730,000 | USD | |
| At 2026-03-31 | 17,628,000 | USD | |
| At 2025-12-31 | -37,000 | USD | |
| At 2025-06-30 | 1,646,000 | USD | |
| At 2025-03-31 | 1,559,000 | USD | |
| At 2024-12-31 | 508,000 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 277,000 | USD | |
| At 2025-12-31 | 377,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 1,359,000 | USD | |
| At 2025-12-31 | 1,207,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2026-06-30 | 2,006,000 | USD | |
| At 2025-12-31 | 3,024,000 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -6,356,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -13,254,000 | USD | 181 |
| 2026-01-01 to 2026-03-31 | -6,898,000 | USD | 90 |
| 2025-04-01 to 2025-06-30 | -6,462,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -11,284,000 | USD | 181 |
| 2025-01-01 to 2025-03-31 | -4,822,000 | USD | 90 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -6,348,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -13,240,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | -6,448,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -11,261,000 | USD | 181 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | -8,932,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -15,867,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | -6,565,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | -11,378,000 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 2,968,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 6,049,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 2,543,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 5,450,000 | USD | 181 |
Nonoperating interest expense
Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 203,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 392,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 9,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 9,000 | USD | 181 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 234,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | 287,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | 68,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 115,000 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-04-01 to 2026-06-30 | 428,000 | USD | 91 |
| 2026-01-01 to 2026-06-30 | -190,000 | USD | 181 |
| 2025-04-01 to 2025-06-30 | -897,000 | USD | 91 |
| 2025-01-01 to 2025-06-30 | 139,000 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2026-01-01 to 2026-06-30 | -71,000 | USD | 181 |
| 2025-01-01 to 2025-06-30 | 963,000 | USD | 181 |
Inspect the source
- Entity
- Serina Therapeutics, Inc. / CIK 0001708599
- Captured
- 2026-09-21T17:26:34.443Z
- SEC response SHA-256
0bf2877f0ae23c086a1e0a1838180a13fde4d4f9e8b48e7e5486890aa9dadc58
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001708599.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))